-
Roche continues to be impacted by biosimilars in the first quarter, total sales of oncology business drops 19%
Time of Update: 2021-05-09
Avastin's sales during the quarter fell sharply by 42% to 863 million Swiss francs.
Roche recently released the results of a first-in-class positive study showing that Tecentriq can prevent postoperative recurrence or death in patients with early-stage non-small cell lung cancer.
-
Sanofi Sarclisa's combination of carfilzomib and dexamethasone is approved in the EU for the treatment of MM
Time of Update: 2021-05-09
15 months, the pre-planned interim analysis received Sarclisa plus carfilzomib and dexamethasone (Sarclisa combined Treatment group; n=179) The median PFS of the treated patients has not yet reached.
-
Substitution of President of Merck China
Time of Update: 2021-05-09
, USA, decided to leave Merck & Co. After Luo Wanli leaves office, Tian Anna, the current president and managing director of Merck Canada, will take over the current position of Luo Wanli from June 1.
-
The U.S. FDA and CDC jointly announce the resumption of Johnson & Johnson's new crown vaccination
Time of Update: 2021-05-09
A few days ago, after a comprehensive safety review, including two meetings of the CDC Immunization Practice Advisory Committee, the US FDA and the US Centers for Disease Control and Prevention (CDC) announced that they would cancel the recommendation to suspend the use of Johnson & Johnson's new crown vaccine in the United States and resume the vaccine.
-
Can the breakthrough of 15 kg weight loss be reproduced?
Time of Update: 2021-05-09
On April 21, 2021, Novo Nordisk announced that it will launch a pivotal phase 3a clinical trial to test oral smeglutide in approximately 1,000 obese or overweight patients with comorbidities.
-
Medical representatives were investigated for involvement of two pharmaceutical companies
Time of Update: 2021-05-09
According to the "Measures for the Administration of the Recordation of Medical Representatives (Trial)", the law enforcement officers of the Municipal Supervision and Administration Office filed and investigated the sales activities of medical representatives in pharmacies.
-
Qilu Pharmaceutical Duloxetine Hydrochloride Enteric-coated Capsules Will Pass Consistency Evaluation
Time of Update: 2021-05-09
Recently, Qilu Pharmaceutical entered the administrative examination and approval stage with duloxetine hydrochloride enteric-coated capsules for imitation of category 4 applications.
0 Chinese Drug Evaluation DatabaseAt present, 12 companies have submitted supplementary applications for the consistency evaluation of duloxetine hydrochloride enteric-coated capsules or submitted for production under the new classification.
-
Guangdong Medical Insurance Bureau issued a mass purchase notice covering 80% of large varieties of drugs
Time of Update: 2021-05-09
If the number of generic drugs with the same generic name and the same dosage form that have been evaluated on the online drug exceeds 3, the products that have not been evaluated will no longer be included in the provincial mass procurement and online procurement.
-
Taiji Group Caffeine Citrate Injection Obtained Drug Registration Certificate
Time of Update: 2021-05-09
(abbreviated as: Southwest Pharmaceutical), received a drug registration certificate for caffeine citrate injection issued by the National Medical Products Administration.
66 million yuan, and the total sales in Chinese urban public hospitals in the first half of 2020 were about 113.
-
Hengrui PD-1 nasopharyngeal carcinoma indication is about to be approved
Time of Update: 2021-05-09
The indications to be approved this time are: for the treatment of advanced nasopharyngeal carcinoma patients who have previously received second-line or above chemotherapy and have advanced or intolerable disease.
-
Roche trastuzumab subcutaneous injection application for listing
Time of Update: 2021-05-09
In the Phase III clinical study code-named SafeHER, the safety and tolerability of Herceptin Hylecta in the adjuvant treatment of Her2-positive breast cancer were consistent with the previous safety features of intravenous Herceptin, and no new safety signals were found.
-
This Guangdong pharmaceutical company has reviewed a large variety of 6 billion injections
Time of Update: 2021-05-09
Source: Mi Neiwang database, NMPA Medical Network News, April 25, April 23, NMPA official website showed that Guangdong Jincheng Jinsu Pharmaceutical's ceftazidime for injection passed the consistency evaluation.
-
The clinical application of ASKC852 tablets of Osaikang was undertaken by CDE
Time of Update: 2021-05-09
On April 23, Osaikang declared a new drug clinical application for the first class of new drug ASKC852 tablets, which was undertaken by CDE, which is a small molecule immunomodulatory drug.
-
Review of Qilu Pharmaceutical Granisetron Hydrochloride Injection
Time of Update: 2021-05-09
On April 26, the NMPA official website updated the drug approval document information, and Qilu Pharmaceutical's Granisetron Hydrochloride Injection was the first to pass the consistency evaluation.
-
Jiangsu Coast Pharmaceutical Olanzapine Tablets Entering the Administrative Approval Stage Will Be Appraised
Time of Update: 2021-05-09
com, olanzapine tablets exceeded 4 billion yuan in terminal sales in China's urban public hospitals, county-level public hospitals, urban community centers, township health centers (referred to as Chinese public medical institutions), and physical pharmacies in Chinese cities in 2019.
-
The first copy of Howen's "Varenicline Tartrate Tablet" is about to be approved for adult smoking cessation
Time of Update: 2021-05-09
On April 22, the listing application for the new four-category generic drug "Varenicline Tartrate" by Hausen Pharmaceuticals entered the approval status, and it is expected to be approved soon, becoming the first domestic imitation of this product.
-
Roche Trastuzumab Injection's marketing application was accepted by CDE
Time of Update: 2021-05-09
The US FDA approved the marketing of Herceptin Hylecta® based on the results of the following clinical trials:1) In a phase III HannaH study, neoadjuvant therapy and adjuvant therapy using Herceptin Hylecta® + chemotherapy were compared with intravenous Herceptin® + chemotherapy.
-
Qilu Cefepime Hydrochloride for Injection passed the consistency evaluation
Time of Update: 2021-05-09
On April 20, the official website of the State Food and Drug Administration showed that Qilu Pharmaceutical's cefepime hydrochloride for injection passed the consistency evaluation and was the first in China.
-
Throwing watermelon and picking sesame seeds?
Time of Update: 2021-05-09
For example, there was a period of early screening for thyroid cancer in South Korea, which increased the number of tumor patients by more than ten times, but died of The patient with this disease has hardly changed.
-
5 commonly used drugs are discontinued and recalled: Amoxicillin Granules, Huanglian Shangqing Tablets...
Time of Update: 2021-05-09
According to the first notice of 2021, the province has recently spot-checked 1,863 batches of drugs from 797 varieties of 38 drug manufacturers, 492 drug distributors, and 160 medical institutions.
